BAM
IBB icon

Belpointe Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$881K Sell
6,964
-166
-2% -$21K 0.04% 398
2025
Q1
$912K Sell
7,130
-440
-6% -$56.3K 0.05% 358
2024
Q4
$1.12M Buy
7,570
+21
+0.3% +$3.11K 0.07% 281
2024
Q3
$1.1M Buy
7,549
+3,678
+95% +$536K 0.07% 286
2024
Q2
$531K Sell
3,871
-126
-3% -$17.3K 0.04% 443
2024
Q1
$549K Sell
3,997
-248
-6% -$34K 0.04% 417
2023
Q4
$577K Sell
4,245
-343
-7% -$46.6K 0.05% 328
2023
Q3
$561K Buy
4,588
+108
+2% +$13.2K 0.06% 303
2023
Q2
$569K Sell
4,480
-12,373
-73% -$1.57M 0.06% 283
2023
Q1
$2.18M Sell
16,853
-12,336
-42% -$1.59M 0.12% 183
2022
Q4
$3.83M Sell
29,189
-5,612
-16% -$737K 0.23% 83
2022
Q3
$4.07M Buy
34,801
+16,121
+86% +$1.89M 0.28% 70
2022
Q2
$2.2M Buy
18,680
+1,843
+11% +$217K 0.15% 149
2022
Q1
$2.19M Sell
16,837
-4,984
-23% -$649K 0.13% 162
2021
Q4
$3.33M Buy
21,821
+1,469
+7% +$224K 0.21% 100
2021
Q3
$3.29M Buy
20,352
+12,375
+155% +$2M 0.22% 89
2021
Q2
$1.31M Buy
7,977
+421
+6% +$68.9K 0.09% 234
2021
Q1
$1.14M Sell
7,556
-1,291
-15% -$194K 0.1% 227
2020
Q4
$1.34M Buy
8,847
+1,805
+26% +$273K 0.12% 191
2020
Q3
$953K Sell
7,042
-834
-11% -$113K 0.11% 214
2020
Q2
$1.08M Buy
7,876
+866
+12% +$118K 0.14% 156
2020
Q1
$755K Sell
7,010
-853
-11% -$91.9K 0.13% 182
2019
Q4
$948K Buy
7,863
+685
+10% +$82.6K 0.12% 188
2019
Q3
$714K Buy
7,178
+9
+0.1% +$895 0.12% 198
2019
Q2
$782K Buy
+7,169
New +$782K 0.15% 140
2019
Q1
Sell
-6,666
Closed -$643K 484
2018
Q4
$643K Sell
6,666
-1,456
-18% -$140K 0.16% 138
2018
Q3
$990K Buy
8,122
+2,192
+37% +$267K 0.16% 126
2018
Q2
$651K Sell
5,930
-28,779
-83% -$3.16M 0.18% 107
2018
Q1
$3.71M Buy
34,709
+26,299
+313% +$2.81M 1.08% 11
2017
Q4
$898K Sell
8,410
-2,976
-26% -$318K 0.2% 108
2017
Q3
$3.8M Buy
+11,386
New +$3.8M 0.89% 15